Advertisement
Canada markets close in 2 hours 32 minutes
  • S&P/TSX

    21,825.19
    +116.75 (+0.54%)
     
  • S&P 500

    4,986.40
    -24.72 (-0.49%)
     
  • DOW

    38,006.05
    +230.67 (+0.61%)
     
  • CAD/USD

    0.7277
    +0.0014 (+0.19%)
     
  • CRUDE OIL

    83.47
    +0.74 (+0.89%)
     
  • Bitcoin CAD

    88,294.87
    +1,303.07 (+1.50%)
     
  • CMC Crypto 200

    1,380.11
    +67.49 (+5.14%)
     
  • GOLD FUTURES

    2,414.30
    +16.30 (+0.68%)
     
  • RUSSELL 2000

    1,947.28
    +4.32 (+0.22%)
     
  • 10-Yr Bond

    4.6210
    -0.0260 (-0.56%)
     
  • NASDAQ

    15,380.11
    -221.38 (-1.42%)
     
  • VOLATILITY

    18.57
    +0.57 (+3.17%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6827
    +0.0006 (+0.09%)
     

2 Upcoming FDA Approval Decisions That Investors Should Really Watch

In this Motley Fool Live video recorded on Oct. 13, Fool contributors Keith Speights and Brian Orelli discuss two upcoming U.S. Food and Drug Administration (FDA) approval decisions that investors should keep an eye on. Keith Speights: Brian, on another note, the FDA is set to make several important approval decisions in the fourth quarter. Brian Orelli: Biomarin (NASDAQ: BMRN) has one coming up on Nov. 20.